Sep
18
2020

Fibrotic Eye Disease Responds to Nicotinamide (Vitamin B3)

Fibrotic Eye Disease Responds to Nicotinamide (Vitamin B3)

Fibrotic Eye Disease Responds to Nicotinamide (Vitamin B3)

About Ray Schilling

Dr. Ray Schilling born in Tübingen, Germany and Graduated from Eberhard-Karls-University Medical School, Tuebingen in 1971. Once Post-doctoral cancer research position holder at the Ontario Cancer Institute in Toronto, is now a member of the American Academy of Anti-Aging Medicine (A4M).

Speak Your Mind

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.